Pay in 4 interest-free payments of $5.20 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
02 Cloudy vial after reconstitution A cloudy or particle-containing vial should not be used
Semaglutide is prescribed for lowering blood sugar levels for individuals with type 2 diabetes (T2D) and weight management for those who are overweight or have obesity with at least one weight-related comorbidity.[1-5] Individuals taking semaglutide may lose up to 15% of their body weight.[5] However, weight loss results may vary depending on your starting weight, comorbidities, other medications, and lifestyle choices.[1-5] Although the exact mechanism by which semaglutide causes weight loss is still under investigation, it has the potential to reduce appetite, thereby reducing caloric intake.[1-3] You may feel more tired than usual due to the reduced calorie intake while taking semaglutide
Understanding how to calculate peptide dosages is a foundational skill that applies to every reconstituted peptide, not just tirzepatide
What Current Evidence and Clinical Trials Tell Us The key published evidence is a 2023 Phase 2 RCT (Jastreboff et al.) showing substantial weight loss and predominantly mild-to-moderate GI side effects
Early studies suggest it may be even more effective than current options, but it is not yet available for general use
Side effect profiles differ across compounds as well
US$ 28.53
US$ 26.64
US$ 29.90
